Chad Bjorklund
About Chad Bjorklund
Chad Bjorklund is a Principal Scientist at Bristol-Myers Squibb with over a decade of experience in the biopharmaceutical industry, specializing in biochemistry and cancer research.
Current Role at Bristol-Myers Squibb
Chad Bjorklund is currently serving as a Principal Scientist at Bristol-Myers Squibb in the Greater New York City Area. He joined the company in November 2019 and has brought over a decade of experience in the biopharmaceutical industry to his current role. Bjorklund's work includes significant contributions to scientific research and the development of new biopharmaceutical methodologies.
Previous Experience at Celgene
Before his current role, Chad Bjorklund worked at Celgene as a Senior Scientist. He was with the company from 2013 to 2019, a span of six years. During his tenure at Celgene, Bjorklund focused on various biopharmaceutical projects, further honing his skills in biochemistry and cancer research.
Research at MD Anderson Cancer Center
Chad Bjorklund served as a Postdoctoral Research Fellow at MD Anderson Cancer Center from 2007 to 2013 in the Houston, Texas Area. Over the course of six years, he worked on significant research projects related to cancer. His work contributed to advancements in cancer research and scientific publications in the field of biochemistry.
Educational Background
Chad Bjorklund earned his Doctor of Philosophy (Ph.D.) in Biochemistry and Biophysics from Washington State University, where he studied from 2002 to 2006. Prior to that, he obtained his Bachelor’s Degree in Biochemistry from Boise State University, completing his studies from 1998 to 2002. His extensive educational background has equipped him with a strong foundation in biochemistry and biophysics.
Expertise and Collaborations
With a strong background in cancer research and biochemistry, Chad Bjorklund has contributed to several scientific publications. He has also mentored junior scientists and researchers, sharing his expertise and guiding new talent in the field. Additionally, Bjorklund has been involved in collaborative research projects with other leading scientists, furthering advancements in biopharmaceuticals and cancer research.